AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Precision BioSciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Aquilo Capital, L.P.
Signature:/s/ Marc Schneidman
Name/Title:Aquilo Capital Management, LLC, its General Partner
Date:08/06/2025
Aquilo Capital Management, LLC
Signature:/s/ Marc Schneidman
Name/Title:Managing Member
Date:08/06/2025
Marc Schneidman
Signature:/s/ Marc Schneidman
Name/Title:Marc Schneidman
Date:08/06/2025
Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

59.05M
10.30M
10.29%
46.23%
10.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
DURHAM